ANVO Pharma Group is a Canadian-based science and research-focused pharmaceutical group specializing in developing, manufacturing, marketing, and distributing high-quality generic specialty products globally.

ANVO Pharma Group’s headquarters is based in London, Ontario. ANVO’s state-of-the-art facility features a research and development laboratory and a drug manufacturing plant specializing in medication to treat heart disease, diabetes, and hepatitis. ANVO’s flexible manufacturing capabilities offer format dosage in tablets, capsules, and sachets.

Furthermore, ANVO is excited to introduce Multiple-Unit Pellet Systems (MUPS), a leading technology for drug-controlled release which offers outstanding therapeutic advantages among its variants.

Besides its core business, ANVO Pharma Group offers a full-service Contract Manufacturing Organization and Contract Packaging Organization for partners worldwide.

ANVO’s mission, “global healing power”, aligns with everything they do to become an innovative leader for the future.